Breast cancer patients treated with anthracycline-based chemotherapy regimens may be at greater risk of neurocognitive problems than those given nonanthracycline regimens

7 Dec
Breast cancer patients treated with anthracycline-based chemotherapy regimens may be at greater risk of neurocognitive problems than those given nonanthracycline regimens

A meta-analysis of Laurentiis De, Italy, to compare the DFS and overall survival of patients with high risk of early breast cancer, compared with the addition of paclitaxel in the treatment of patients with an early stage of the disease. … Read More »